Sir Jonathan Van-Tam joins Pulselight to support its mission to transform the UK health system by reducing waiting lists, driving efficiencies and improving patient outcomes

LONDON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pulselight, a data analytics company that has developed software AI products capable of transforming the UK health system, today announces the appointment of Sir Jonathan Van-Tam MBE, FMedSci, as an Advisor, effective immediately.

Sir Jonathan will use his extensive experience in HM Government, academia and across the health industry to strengthen Pulselight’s offering to support the NHS with maximising resources, preventing ill-health caused by obesity, tackling health inequalities and the shift of care into the community.

As the Government sharpens its focus on technology and data as drivers of NHS transformation, Sir Jonathan will leverage his deep expertise in advising how companies can deliver and communicate value across the health system. His insights will guide the company’s efforts to showcase its breadth of applications across various care settings. Sir Jonathan’s experience working at the forefront of UK health policy will help shape the company’s efforts to support the Government and NHS on addressing the country’s most urgent public health challenges.

Sir Jonathan served as Deputy Chief Medical Officer to HM Government from 2017 to 2022, playing a central role in shaping the UK's response to the COVID-19 pandemic. Over the course of his career, he has led major global health initiatives in partnership with the World Health Organization and Public Health England, focusing on pandemic preparedness and response. His extensive experience in the pharmaceutical industry includes senior leadership roles at SmithKline Beecham (now part of GSK), Roche, and Aventis Pasteur MSD (now part of Sanofi). A distinguished academic, Sir Jonathan is a former Pro-Vice Chancellor of the University of Nottingham and currently works as an independent consultant in the biopharmaceutical sector.

Irene Manautou, Founder and CEO at Pulselight, said: “We are thrilled to welcome Sir Jonathan as an Advisor. His appointment is an important milestone in Pulselight’s UK growth as we look to bring the proven success of our AI-driven solutions from the US to support the NHS. With his unique expertise at the intersection of government, healthcare and innovation, Sir Jonathan will help us demonstrate how Pulselight’s technology can play a central role in reducing waiting lists, improving patient outcomes and enabling a more efficient health system.”

Sir Jonathan Van-Tam, Advisor at Pulselight, said: “Pulselight brings a powerful and truly bespoke solution to UK healthcare at a pivotal moment as the Government accelerates its technology-enabled strategy to reduce waiting lists and improve patient outcomes. I look forward to working with the team and showcasing the power of Pulselight’s analytics ecosystem to make sure it delivers real and lasting benefits for patients and the health service throughout the UK.”

For further information, please contact:

Pulselight (Team@Pulselight.com)

Irene Manautou

For Media Enquiries:

5654 & Company (Pulselight@5654.co.uk)

Matthew Neal, Partner

Charlotte Dawson, Associate Director

NOTES TO EDITORS

Sir Jonathan Van-Tam has joined Pulselight as an Advisor on a part-time basis.

Pulselight – a data analytics company – has developed analytical products capable of transforming the health system.

Already delivering results in the US, Pulselight’s technologies maximise resources, deliver preventive health care, tackle health inequalities, and empower community health workers.

For more information, please visit: https://www.pulselight.com/

This item of content is a press release from a third party provider who make no warranties or representations in connection with this content and therefore PA can make no warranties in respect of its use.

Tags

More Like This

Sir Jonathan Van-Tam joins 5654 & Company as Senior Advisor

HealthTech Leader Cera Strengthens Advisory Board With Addition of New Members

ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth

Upp.Technologies Ltd expands management team with the appointment of Jonathan Gale as CEO

Affidea Group appoints Frans van Houten, Former CEO of Philips, as a new Supervisory Board member

Prime Minister turbocharges medical research

MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption

Tech experts to shape government digital vision to drive innovation and boost public services